Michele Wl Teng

11PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTe mātauranga reo Māori (Māori language education)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.

Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis

|Nov 17, 2020
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy.

Celia Jacoberger-Foissac, Stephen J Blake, Jing Liu

|Apr 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.

Ailin Lepletier, Jason Madore, Jake S O'Donnell

|Jan 30, 2020
Control of Metastases via Myeloid CD39 and NK Cell Effector Function.

Juming Yan, Xian-Yang Li, Amelia Roman Aguilera

|Dec 13, 2019
MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.

Juming Yan, Stacey Allen, Elizabeth McDonald

|Nov 17, 2019
IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection.

Huimeng Wang, Lars Kjer-Nielsen, Mai Shi

Pageof 2

Frequent Collaborators

3 joint publications

Elizabeth McDonald

3 joint publications

Juming Yan

2 joint publications

Jason Madore

2 joint publications

Georgina V Long